• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$26.40 -$0.12 (-0.45%)

REAL-TIME: Last trade at

PerkinElmer, Inc.

NYSE:PKI

PerkinElmer Remains Neutral - Analyst Blog

PerkinElmer Beats on Lower Profit - Analyst Blog

U.S. stock gains hinge on Apple, blue-chip results

MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results

The Best Dividends On April 18, 2012

PerkinElmer, Inc. - Momentum

Zacks Releases Four Powerful ''Buy'' Stocks: Encore Wire, Snap-on, PerkinElmer and FreightCar Americ

How Fast Is the Cash at PerkinElmer?

PerkinElmer Passes This Key Test

PerkinElmer Beats in 4Q, Posts Loss - Analyst Blog

PerkinElmer Shares Popped: What You Need to Know

Can Varian's Stock Be Cheap by the Numbers?

Is This Showing You a Glimpse of PerkinElmer's Future?

PerkinElmer Passes This Key Test

PerkinElmer Remains Neutral - Analyst Blog

This Just In: More Upgrades and Downgrades

Benefits of Mapping Human Genome

5-Star Stocks Poised to Pop: PerkinElmer

Growth Stocks Look Pricey. Favor Free Cash

5 of Last Week's Biggest Winners

Whoa! What Just Happened to My Stock?

UPDATE 2-PerkinElmer to buy Caliper for $600 mln

The 15 Most-Watched Life-Sciences Stocks

UPDATE 1-PerkinElmer 2nd quarter tops forecasts

PerkinElmer 2Q Profit Down 50% On Expenses; Raises Outlook

PerkinElmer's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Here's How Harvard Bioscience May Be Failing You

Wall Street Breakfast: Must-Know News

PerkinElmer Beats on All Fronts

UPDATE 1-PerkinElmer profit tops Street, raises '11 outlook

PerkinElmer's CEO Discusses Q1 2011 Results - Earnings Call Transcript

PerkinElmer's CEO Discusses Q1 2011 Results - Earnings Call Transcript

The Best and Worst Medical Device Stocks

Cramer's Mad Money - Tech Is Not a Monolith (3/24/11)

Hedge Fund Ratings for Cramer's Stock Picks

PerkinElmer Boosts Software Offerings In 2 Deals Valued At $220 Million

Cramer's Stop Trading! FedEx Delivers, But UPS Is Better (3/17/11)

$3B Hedge Fund Bullish About These Stocks: Should You Be, Too?

Wall Street Breakfast: Must-Know News

PerkinElmer Isn't For Sale, CEO Says; Shares Slide

See More Articles...